WDR5 and neoplasm: Inhibiting WDR5 with small‐molecule inhibitor WDR5‐0103 significantly suppresses HBV and HBx‐driven tumor growth, suggesting that WDR5 plays a critical role in HBV‐induced liver cancer [102].